Cargando…
Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis
INTRODUCTION: Syndrome of inappropriate antidiuresis (SIAD) can be a complication of hypothalamus-pituitary surgery. The use of tolvaptan in this setting is not well established, hence the primary aim of this study was to assess the sodium correction rates attained with tolvaptan compared with stand...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181462/ https://www.ncbi.nlm.nih.gov/pubmed/34108941 http://dx.doi.org/10.3389/fendo.2021.689887 |
_version_ | 1783704097058193408 |
---|---|
author | Indirli, Rita Ferreira de Carvalho, Júlia Cremaschi, Arianna Mantovani, Beatrice Sala, Elisa Serban, Andreea Liliana Locatelli, Marco Bertani, Giulio Carosi, Giulia Fiore, Giorgio Tariciotti, Leonardo Arosio, Maura Mantovani, Giovanna Ferrante, Emanuele |
author_facet | Indirli, Rita Ferreira de Carvalho, Júlia Cremaschi, Arianna Mantovani, Beatrice Sala, Elisa Serban, Andreea Liliana Locatelli, Marco Bertani, Giulio Carosi, Giulia Fiore, Giorgio Tariciotti, Leonardo Arosio, Maura Mantovani, Giovanna Ferrante, Emanuele |
author_sort | Indirli, Rita |
collection | PubMed |
description | INTRODUCTION: Syndrome of inappropriate antidiuresis (SIAD) can be a complication of hypothalamus-pituitary surgery. The use of tolvaptan in this setting is not well established, hence the primary aim of this study was to assess the sodium correction rates attained with tolvaptan compared with standard treatments (fluid restriction and/or hypertonic saline). Furthermore, we compared the length of hospital stay in the two treatment groups and investigated the occurrence of overcorrection and side effects including osmotic demyelination syndrome. METHODS: We retrospectively reviewed 308 transsphenoidal surgical procedures performed between 2011 and 2019 at our hospital. We selected adult patients who developed post-operative SIAD and recorded sodium monitoring, treatment modalities and outcomes. Correction rates were adjusted based on pre-treatment sodium levels. RESULTS: Twenty-nine patients (9.4%) developed post-operative SIAD. Tolvaptan was administered to 14 patients (median dose 15 mg). Standard treatments were employed in 14 subjects (fluid restriction n=11, hypertonic saline n=1, fluid restriction and hypertonic saline n=2). Tolvaptan yielded higher adjusted sodium correction rates (12.0 mmolL(-1)/24h and 13.4 mmolL(-1)/48h) than standard treatments (1.8 mmolL(-1)/24h, p<0.001, and 4.5 mmolL(-1)/48h, p=0.004, vs. tolvaptan). The correction rate exceeded 10 mmolL(-1)/24h or 18 mmolL(-1)/48h in 9/14 and 2/14 patients treated with tolvaptan, respectively, and in no patient who received standard treatments. No side effects including osmotic demyelination occurred. Tolvaptan was associated with a shorter hospital stay (11vs.15 days, p=0.01). CONCLUSIONS: Tolvaptan is more effective than fluid restriction (with or without hypertonic saline) and allows for a shortened hospital stay in patients with SIAD after transsphenoidal surgery. However, its dose and duration should be carefully tailored, and close monitoring is recommended to allow prompt detection of overcorrection. |
format | Online Article Text |
id | pubmed-8181462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81814622021-06-08 Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis Indirli, Rita Ferreira de Carvalho, Júlia Cremaschi, Arianna Mantovani, Beatrice Sala, Elisa Serban, Andreea Liliana Locatelli, Marco Bertani, Giulio Carosi, Giulia Fiore, Giorgio Tariciotti, Leonardo Arosio, Maura Mantovani, Giovanna Ferrante, Emanuele Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Syndrome of inappropriate antidiuresis (SIAD) can be a complication of hypothalamus-pituitary surgery. The use of tolvaptan in this setting is not well established, hence the primary aim of this study was to assess the sodium correction rates attained with tolvaptan compared with standard treatments (fluid restriction and/or hypertonic saline). Furthermore, we compared the length of hospital stay in the two treatment groups and investigated the occurrence of overcorrection and side effects including osmotic demyelination syndrome. METHODS: We retrospectively reviewed 308 transsphenoidal surgical procedures performed between 2011 and 2019 at our hospital. We selected adult patients who developed post-operative SIAD and recorded sodium monitoring, treatment modalities and outcomes. Correction rates were adjusted based on pre-treatment sodium levels. RESULTS: Twenty-nine patients (9.4%) developed post-operative SIAD. Tolvaptan was administered to 14 patients (median dose 15 mg). Standard treatments were employed in 14 subjects (fluid restriction n=11, hypertonic saline n=1, fluid restriction and hypertonic saline n=2). Tolvaptan yielded higher adjusted sodium correction rates (12.0 mmolL(-1)/24h and 13.4 mmolL(-1)/48h) than standard treatments (1.8 mmolL(-1)/24h, p<0.001, and 4.5 mmolL(-1)/48h, p=0.004, vs. tolvaptan). The correction rate exceeded 10 mmolL(-1)/24h or 18 mmolL(-1)/48h in 9/14 and 2/14 patients treated with tolvaptan, respectively, and in no patient who received standard treatments. No side effects including osmotic demyelination occurred. Tolvaptan was associated with a shorter hospital stay (11vs.15 days, p=0.01). CONCLUSIONS: Tolvaptan is more effective than fluid restriction (with or without hypertonic saline) and allows for a shortened hospital stay in patients with SIAD after transsphenoidal surgery. However, its dose and duration should be carefully tailored, and close monitoring is recommended to allow prompt detection of overcorrection. Frontiers Media S.A. 2021-05-24 /pmc/articles/PMC8181462/ /pubmed/34108941 http://dx.doi.org/10.3389/fendo.2021.689887 Text en Copyright © 2021 Indirli, Ferreira de Carvalho, Cremaschi, Mantovani, Sala, Serban, Locatelli, Bertani, Carosi, Fiore, Tariciotti, Arosio, Mantovani and Ferrante https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Indirli, Rita Ferreira de Carvalho, Júlia Cremaschi, Arianna Mantovani, Beatrice Sala, Elisa Serban, Andreea Liliana Locatelli, Marco Bertani, Giulio Carosi, Giulia Fiore, Giorgio Tariciotti, Leonardo Arosio, Maura Mantovani, Giovanna Ferrante, Emanuele Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis |
title | Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis |
title_full | Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis |
title_fullStr | Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis |
title_full_unstemmed | Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis |
title_short | Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis |
title_sort | tolvaptan in the management of acute euvolemic hyponatremia after transsphenoidal surgery: a retrospective single-center analysis |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181462/ https://www.ncbi.nlm.nih.gov/pubmed/34108941 http://dx.doi.org/10.3389/fendo.2021.689887 |
work_keys_str_mv | AT indirlirita tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT ferreiradecarvalhojulia tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT cremaschiarianna tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT mantovanibeatrice tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT salaelisa tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT serbanandreealiliana tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT locatellimarco tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT bertanigiulio tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT carosigiulia tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT fioregiorgio tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT tariciottileonardo tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT arosiomaura tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT mantovanigiovanna tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis AT ferranteemanuele tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis |